Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients

Table 1

Comparison of baseline characteristics and inflammatory parameters between two groups.

Parameters	Nebivolol group	Metoprolol group
Age (years)	52.46 ± 8.32	54.60 ± 7.82
Male ( = %)	35 (68.6)	32 (65.3 )
BMI (kg/m^2)
Before	26.95 ± 4.82	27.24 ± 3.86
After	26.25 ± 3.56	27.45 ± 4.25
SBP (mmHg)
Before	149 ± 15	148 ± 14
After	131 ± 11	136 ± 8
	<0.00	<0.00
DBP (mmHg)
Before	92 ± 10	93 ± 11
After	80 ± 11	83 ± 10
	<0.00	<0.00
WBC count × 10^9/L
Before	9.4 ± 3.8	9.2 ± 3.6
After	7.6 ± 3.1	9.3 ± 4.72
Neutrophil count × 10^9/L
Before	7.5 ± 2.8	7.6 ± 3.2
After	4.9 ± 3.2	7.4 ± 4.5
Lymphocyte count × 10^9/L
Before	2.1 ± 0.7	2.2 ± 1.62
After	2.4 ± 0.8	2.1 ± 1.45
NLR
Before	4.4 ± 2.2	4.5 ± 3.2
After	2.2 ± 1.5	4.4 ± 2.7

Values are mean ± SD;paired t-test; independent sample t-test; Mann–Whitney U test.